The myeloperoxidase system of human phagocytes generates Nε-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation
Melissa M. Anderson(Washington University in St. Louis), Jay W. Heinecke(University of Washington)
Cited by 348
Related Papers
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
|Journal of Clinical Investigation|1994|1.3k
3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima.
|Journal of Clinical Investigation|1997|843
Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation.
|Journal of Clinical Investigation|1997|387
Bioluminescence imaging of myeloperoxidase activity in vivo
|Nature Medicine|2009|340
Neuronal expression of myeloperoxidase is increased in Alzheimer's disease
|Journal of Neurochemistry|2004|336